Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

CUSIP: 761330109

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
-1,072,002
Put/Call ratio
149%
SEC-reported price per share
$25.14
Number of holders
151
Value change
-$26,647,818
Number of buys
82
Open additional details 1 more signal available
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
104,661,494

Security key

761330109

Report period

Q3 2020

Institutions

151

Top holders

10

Ownership snapshot

Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F Lead comparable stake: 4.2% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 4.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 4.2%
JPMORGAN CHASE & CO 3.8%
WELLINGTON MANAGEMENT GROUP LLP 3.6%
ArrowMark Colorado Holdings LLC 3.4%
FRANKLIN RESOURCES INC 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
4.2%
$108,406,000
4,439,200 shares
30 Jun 2020
JPMORGAN CHASE & CO
13F
Company
13F
3.8%
$98,358,000
4,027,774 shares
30 Jun 2020
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
3.6%
$91,741,000
3,756,798 shares
30 Jun 2020
ArrowMark Colorado Holdings LLC
13F
Company
13F
3.4%
$87,417,000
3,579,711 shares
30 Jun 2020
FRANKLIN RESOURCES INC
13F
Company
13F
3.3%
$83,309,000
3,466,888 shares
30 Jun 2020
Essex Woodlands Management, Inc.
13F
Company
13F
3.2%
$81,613,000
3,342,047 shares
30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
151
Shares
49,472,050
Rows available
151
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
138
Q3 2020 holders
151
Holder diff
13
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .